← Research LibraryThe BriefFY2026 10-K · headline figures audited against SEC data
Stanley Black & Decker remained profitable and cash-positive through another revenue decline, but incomplete margin comparability and a long restructuring leave the recovery unfinished.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 1.5%Watch
- Profitability — Net income grew 36.6% to $401.9M from $294.3MOK
- Cash flow — Free cash flow declined 8.6% to $687.9M from $753MWatch
- Margins — Comparable operating-margin data was unavailableNote
- Accounting — Cash-positive portfolio reset amid contractionNote
- Insiders — 0 purchases and 1 salesNote
Business
Stanley Black & Decker manufactures tools, outdoor products, fasteners and engineered industrial products.
Where the revenue comes from
Fiscal 2025, as STANLEY BLACK & DECKER, INC. reports it. History and quarterly detail are in the app.
- Tools & Outdoor$13.2B
- Engineered Fastening$2.0B
Leadership changes
From STANLEY BLACK & DECKER, INC.'s own filings, the day they're filed.
- Donald Allan Jr · departureeff. 2026-10-01
- Stanley Black · director · departureeff. 2026-01-23
- Andrea Ayers · directors · departureeff. 2026-01-23
Latest filings
- 8-K · Company announcement2026-07-29
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-06-24
- 10-Q · Quarterly report2026-04-29
- 8-K · Company announcement2026-04-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about STANLEY BLACK & DECKER, INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.